298 related articles for article (PubMed ID: 36972454)
1. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion.
Lamarche C; Ward-Hartstonge K; Mi T; Lin DTS; Huang Q; Brown A; Edwards K; Novakovsky GE; Qi CN; Kobor MS; Zebley CC; Weber EW; Mackall CL; Levings MK
Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2219086120. PubMed ID: 36972454
[TBL] [Abstract][Full Text] [Related]
2. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
3. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
4. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.
Lamarthée B; Marchal A; Charbonnier S; Blein T; Leon J; Martin E; Rabaux L; Vogt K; Titeux M; Delville M; Vinçon H; Six E; Pallet N; Michonneau D; Anglicheau D; Legendre C; Taupin JL; Nemazanyy I; Sawitzki B; Latour S; Cavazzana M; André I; Zuber J
Nat Commun; 2021 Nov; 12(1):6446. PubMed ID: 34750385
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells.
Dawson NAJ; Rosado-Sánchez I; Novakovsky GE; Fung VCW; Huang Q; McIver E; Sun G; Gillies J; Speck M; Orban PC; Mojibian M; Levings MK
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817364
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
[TBL] [Abstract][Full Text] [Related]
7. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
[TBL] [Abstract][Full Text] [Related]
8. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
[TBL] [Abstract][Full Text] [Related]
10. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.
Mohseni YR; Tung SL; Dudreuilh C; Lechler RI; Fruhwirth GO; Lombardi G
Front Immunol; 2020; 11():1608. PubMed ID: 32793236
[TBL] [Abstract][Full Text] [Related]
11. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
12. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
[TBL] [Abstract][Full Text] [Related]
13. T-cell exhaustion in CAR-T-cell therapy and strategies to overcome it.
Yin X; He L; Guo Z
Immunology; 2023 Aug; 169(4):400-411. PubMed ID: 36942414
[TBL] [Abstract][Full Text] [Related]
14. Building a CAR-Treg: Going from the basic to the luxury model.
Rosado-Sánchez I; Levings MK
Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
[TBL] [Abstract][Full Text] [Related]
15.
Suematsu M; Yagyu S; Nagao N; Kubota S; Shimizu Y; Tanaka M; Nakazawa Y; Imamura T
Front Immunol; 2022; 13():770132. PubMed ID: 35154098
[TBL] [Abstract][Full Text] [Related]
16. Exhaustion of CAR T cells: potential causes and solutions.
Kouro T; Himuro H; Sasada T
J Transl Med; 2022 May; 20(1):239. PubMed ID: 35606821
[TBL] [Abstract][Full Text] [Related]
17. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
Front Immunol; 2018; 9():199. PubMed ID: 29467769
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
19. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.
MacDonald KG; Hoeppli RE; Huang Q; Gillies J; Luciani DS; Orban PC; Broady R; Levings MK
J Clin Invest; 2016 Apr; 126(4):1413-24. PubMed ID: 26999600
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CAR-Mediated Tonic Signaling.
Calderon H; Mamonkin M; Guedan S
Methods Mol Biol; 2020; 2086():223-236. PubMed ID: 31707680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
